Researchers from the University of Missouri School of Medicine have shed new light on how the uterus develops, leading to a ...

This article will describe the most salient molecular markers that have been identified in uterine serous cancer, thus far with emphasis on the use of erbB2 (HER2/neu) as the first of a series of ...

As with uterine sarcoma, endometrial carcinoma ... in detecting lesions in the setting of post-treatment unexplained tumor marker elevation appears promising. PET is of great benefit as a ...

Uterine cancer affects 28 in 100,000 women annually. Learn the 5 critical warning signs that could save your life and why ...

Endometrial cancer is one of the few cancers that doesn’t stay quiet. That’s why you should never brush off spotting between periods or any bleeding after menopause. When caught early ...

Cadonilimab plus lenvatinib showed promising antitumor activity in patients with advanced endometrial cancer who have experienced disease progression after prior platinum-based chemotherapy,” said ...

Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli Lilly castoff solely on endometrial cancer. The Watertown, Massachusetts ...

Ultimately, these biomarkers can be used as selection markers for patient stratification. Since mutations in CTNNB1 occur at relatively high frequency in endometrial cancer and hepatocellular ...